20/20 GeneSystems, Inc.
14 articles about 20/20 GeneSystems, Inc.
-
20/20 GeneSystems To Provide Newly FDA Authorized COVID-19 Antibody Blood Test
5/18/2020
20/20 GeneSystems, Inc. announced today that it will offer in its CLIA laboratory a COVID-19 antibody test that received an Emergency Use Authorization (EUA) from the FDA on May 3.
-
20/20 BioResponse to Launch Rapid Coronavirus Test Kits in U.S. following “Green Light” from FDA
3/19/2020
Rapid Antibody Test Generates Results in under 15 minutes from Blood Drop without Laboratory Equipment or Personnel
-
20/20 GeneSystems Announces HSR Clearance For Collaboration And License Agreement With Momenta
2/17/2017
-
20/20 GeneSystems Nabs $4.5 Million, Eyes IPO
2/16/2016
-
Study Shows Use Of 20/20 GeneSystems, Inc.’ Breast Cancer Indexsm Molecular Test Substantially Lowers Medical Costs For ER+ Breast Cancer Patients Compared With Standard Management
9/11/2014
-
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc.
8/21/2014
-
20/20 GeneSystems, Inc. on Hunt for $5 Million to Broaden Lung Cancer Diagnostic’s Market, Launch in Kidney Cancer, CEO Says
5/20/2013
-
20/20 GeneSystems, Inc. Announces the Appointment of Joel Kanter, Chairman of the Board, and Two Additional Board Members Raymond Cypess, DVM/Ph.D. and Lawrence Shulman, Esq.
3/18/2013
-
20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests
10/19/2010
-
20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests
10/19/2010
-
20/20 GeneSystems, Inc. Release: New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine
9/14/2010
-
20/20 GeneSystems, Inc. Licenses Lung Cancer Blood Test to Ortho-Clinical Diagnostics
1/17/2008
-
National Institute of Standards and Technology Awards $2 Million to 20/20 GeneSystems, Inc. for Innovative Tumor Profiling Technology
10/5/2007
-
20/20 GeneSystems, Inc.'s Blood Test Predicts Detects Lung Cancer Years Before CT Scan
8/1/2006